Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit in which most U.S. states accused dozens of drugmakers and executives of fixing prices of generic drugs, causing patients to overpay. In a decision on Tuesday, Chief Judge …
Source: Claims Journal